Recent Developments in the Chemical Biology of Epothilones
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1595-1613
Author(s):
Karl Heinz Altmann
Improving the Targeting of Tubulin-Binding Agents: Lessons from Drug Resistance Studies
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1719-1733
Author(s):
N. M. Verrills and M. Kavallaris
The Epigenetics of Breast Carcinogenesis and Metastasis
Journal:
Current Genomics
Volume:
6
Page:
129-135
Author(s):
S. M.O. Phipps, W. K. Woodfin and T. O. Tollefsbol
Synthesis and Biological Evaluation of 2-, 3-, and 4-Acylaminocinnamyl-Nhydroxyamides as Novel Synthetic HDAC Inhibitors
Journal:
Medicinal Chemistry
Volume:
1
Page:
245-254
Author(s):
A. Mai, S. Massa, R. Pezzi, S. Valente, P. Loidl and G. Brosch
Protein-Protein Interactions in Drug Discovery
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
2
Page:
179-207
Author(s):
P. M. Fischer
Therapeutic Antibodies
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
2
Page:
209-217
Author(s):
J. R. Adair and A. D. G. Lawson
Progress in the Development of Aminopeptidase N (APN/CD13) Inhibitors
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
281-301
Author(s):
Wenfang Xu and Qianbin Li
What they are, How they Work and Why they do What they do? The Story of SV40-derived Gene Therapy Vectors and What They Have to Offer
Journal:
Current Gene Therapy
Volume:
5
Page:
151-165
Author(s):
David S. Strayer, Pierre Cordelier, Rumi Kondo, Bianling Liu, Alexey A. Matskevich, Hayley J. McKee, Carmen N. Nichols, Christine B. Mitchell, Dawn A. Geverd and Martyn K. White
Lipid Nucleoside Conjugates for the Treatment of Cancer
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1079-1089
Author(s):
Richard L. Alexander and Gregory L. Kucera
Targeting Telomerase by Antisense-Based Approaches: Perspectives for New Anti-Cancer Therapies
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1105-1117
Author(s):
M. Folini and N. Zaffaroni